All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.

Citak F. E., Ezer U., Akkaya E., Ozbulbul N., Bahce M., Kurekci A. E.

Haematologica, cilt.91, sa.8 Suppl, 2006 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 91 Sayı: 8 Suppl
  • Basım Tarihi: 2006
  • Dergi Adı: Haematologica
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Anthracyclin-based regimens and all-transretinoic acid (ATRA, tretinoin) as differentiating agent are commonly utilized for the treatment of acute promylelocytic leukemia (APL). There are many adverse effects that may be seen during the use of ATRA in patients with APL. Of these, ATRA-induced myositis is rarely described in adults and rare in the children with APL. Herein, we report an 11-year-old girl with APL who developed ATRA-induced myositis during induction treatment.